Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The E3 Ubiquitin Ligase TRIM65 Negatively Regulates Inflammasome Activation Through Promoting Ubiquitination of NLRP3
Tiantian Tang, Ping Li, Xinhui Zhou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

The therapeutic potential of targeting regulated non-apoptotic cell death
Kamyar Hadian, Brent R. Stockwell
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 723-742
Closed Access | Times Cited: 162
The Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets
Tao Liang, Yang Zhang, Suyuan Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 125
Post-translational control of NLRP3 inflammasome signaling
Meghan E O'Keefe, George Dubyak, Derek W. Abbott
Journal of Biological Chemistry (2024) Vol. 300, Iss. 6, pp. 107386-107386
Open Access | Times Cited: 20
Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics
Yueran Cui, Haiyang Yu, Zhongqi Bu, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 41
The Role of Post-Translational Modifications in Regulation of NLRP3 Inflammasome Activation
Jing Xia, Songhong Jiang, Shiqi Dong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6126-6126
Open Access | Times Cited: 39
Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's disease
Yiqun Yan, Ran Zheng, Yi Liu, et al.
Aging Cell (2023) Vol. 22, Iss. 6
Open Access | Times Cited: 38
NLRP3 Inflammasome: A central player in renal pathologies and nephropathy
Nada T. Henedak, Hanan S. El‐Abhar, Ayman A. Soubh, et al.
Life Sciences (2024) Vol. 351, pp. 122813-122813
Closed Access | Times Cited: 8
Regulation of NLRP3/TRIM family signaling in gut inflammation and colorectal cancer
B.S. Mohapatra, Kousalya Lavudi, Rekha Rani Kokkanti, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189271-189271
Closed Access | Times Cited: 1
Chronic kidney disease and NLRP3 inflammasome: Pathogenesis, development and targeted therapeutic strategies
Gengzhen Huang, Yaodan Zhang, Yingying Zhang, et al.
Biochemistry and Biophysics Reports (2022) Vol. 33, pp. 101417-101417
Open Access | Times Cited: 30
Berberine attenuates depression-like behavior by modulating the hippocampal NLRP3 ubiquitination signaling pathway through Trim65
Lu Yang, Yuzhen Huang, Fengxi Chen, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110808-110808
Closed Access | Times Cited: 17
E3 ligase TRIM65 alleviates intestinal ischemia/reperfusion injury through inhibition of TOX4-mediated apoptosis
Yingjie Huang, Tao Chen, Ming Jiang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway
Meixiu Jiang, Dan Wang, Ning Su, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111494-111494
Closed Access | Times Cited: 6
Posttranslational modifications of NLRP3 and their regulatory roles in inflammasome activation
Ying Qin, Wei Zhao
European Journal of Immunology (2023) Vol. 53, Iss. 10
Open Access | Times Cited: 14
New Strategies for Macrophage Re-Education in Cancer: An Update
Nadia Lampiasi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3414-3414
Open Access | Times Cited: 5
The NLRP3 inflammasome is a potential mechanism and therapeutic target for perioperative neurocognitive disorders
Jiayue Li, Li Li, Jiannan He, et al.
Frontiers in Aging Neuroscience (2023) Vol. 14
Open Access | Times Cited: 12
Intestinal metabolite UroB alleviates cerebral ischemia/reperfusion injury by promoting competition between TRIM65 and TXNIP for binding to NLRP3 inflammasome in response to neuroinflammation
Jing Luo, Yujia Luo, Jialei Chen, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 4, pp. 167056-167056
Closed Access | Times Cited: 4
Unraveling the Role of the NLRP3 Inflammasome in Lymphoma: Implications in Pathogenesis and Therapeutic Strategies
Ioanna Ε. Stergiou, C. Tsironis, Stavros P. Papadakos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2369-2369
Open Access | Times Cited: 4
Ubiquitin-proteasome system: a potential participant and therapeutic target in antiphospholipid syndrome
He Wang, Yuan Tan, Qi Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Ubiquitin Ligases in Control: Regulating NLRP3 Inflammasome Activation
Swarna Beesetti
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
Ubiquitination is a major modulator for the activation of inflammasomes and pyroptosis
Qiuyun Jiang, Zhigang Zhu, Xinliang Mao
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2023) Vol. 1866, Iss. 3, pp. 194955-194955
Closed Access | Times Cited: 10
The role of E3 ubiquitin ligases in bone homeostasis and related diseases
Yuechao Dong, Yangshan Chen, Guixing Ma, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 10, pp. 3963-3987
Open Access | Times Cited: 9
TRIM65 Promotes Malignant Cell Behaviors in Triple-Negative Breast Cancer by Impairing the Stability of LATS1 Protein
Yongbin Lu, Yi Xiao, Jingru Yang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 14
LPS inhibits TRIM65 expression in macrophages and C57BL/6J mouse by activating the ERK1/2 signaling pathway
Xufang Zeng, Xinxin Deng, Yuqi Ni, et al.
Experimental and Therapeutic Medicine (2023) Vol. 25, Iss. 4
Open Access | Times Cited: 8
CHIP protects against septic acute kidney injury by inhibiting NLRP3-mediated pyroptosis
Hao Zhang, Zebin Deng, Yilong Wang, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107762-107762
Open Access | Times Cited: 8
Posttranslational Regulation of Inflammasomes, Its Potential as Biomarkers and in the Identification of Novel Drugs Targets
Sambit K. Nanda, Stefan Vollmer, Ana B. Pérez‐Oliva
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top